3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Small Cell Lung Carcinoma
4
Nasopharyngeal Carcinoma
3
Triple Negative Breast Neoplasms
2
Sarcoma
2
Neoplasm Metastasis
2
Carcinoma, Renal Cell
2
Breast Neoplasms
2
Solid Tumors
1
Recurrence
1
Ovarian Neoplasms
1
Fallopian Tube Neoplasms
1
Esophageal Neoplasms
1
Carcinoma, Ovarian Epithelial
1
Carcinoma, Non-Small-Cell Lung
1
Carcinoma, Hepatocellular
1
Carcinoma, Adenoid Cystic
1
Interventions
Specimen Handling
4
Radiotherapy
4
Radiation
4
Nivolumab
4
pembrolizumab
3
Magnetic Resonance Spectroscopy
3
Ipilimumab
3
Doxorubicin
3
CTLA-4 Antigen
3
Biopsy
3
talimogene laherparepvec
1
peposertib
1
pazopanib
1
liposomal doxorubicin
1
fludarabine
1
cabozantinib
1
aldesleukin
1
X-Rays
1
Trabectedin
1
Ifosfamide
1
Histamine H2 Antagonists
1
Famotidine
1
Dactinomycin
1
Cyclophosphamide
1
BO-112
1
Angptl4 protein, mouse
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Histiocytoma, Malignant Fibrous
×
anlotinib
×
90 days
×
Clear all
No trials found.